Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002259
- Locations
- ๐บ๐ธ
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
Not Applicable
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002002
- Locations
- ๐บ๐ธ
San Francisco Gen Hosp, San Francisco, California, United States
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002003
- Locations
- ๐บ๐ธ
UMDNJ - New Jersy Med School, Newark, New Jersey, United States
๐บ๐ธNew York Univ Med Ctr, New York, New York, United States
๐บ๐ธSaint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
Not Applicable
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002271
- Locations
- ๐บ๐ธ
Johns Hopkins Hosp, Baltimore, Maryland, United States
An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
Not Applicable
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002260
- Locations
- ๐บ๐ธ
Johns Hopkins Hosp, Baltimore, Maryland, United States
A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002254
- Locations
- ๐บ๐ธ
Univ of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
๐บ๐ธMem Sloan - Kettering Cancer Ctr, New York, New York, United States
๐บ๐ธJohns Hopkins Hosp, Baltimore, Maryland, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath